 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 5907 | 回復(fù): 12 | |||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
[交流]
ssci2區(qū)投稿現(xiàn)收到大修，請各位友友幫忙看看呀！ 已有7人參與
|
|||
|
兩月初投的ssci 6.2給回復(fù)了 7月14日前上傳文件。 第一次投稿啊，還是自己一個在做學術(shù)，沒有團隊，所以跪求友友們幫我看看給給意見��！ （第一次寫稿不一定圖片可以加進來，所以把審稿意見等文字版本發(fā)出來了 Referee: 1 Comments to the Author This manuscript studies the impact of two forms of government innovation assistance programs - innovation subsidies and tax refunds - on the R&D production of Chinese pharmaceutical companies. This is a very interesting research topic for us. The study tests a number of hypotheses and draws conclusions through quantitative analysis. However, I would like to see more concrete raw data on the quantitative analysis. Otherwise, I do not find it very convincing. I would also like to see a specific discussion of the differences from previous studies. I believe the paper will be even better if you do so. More specifically, I am worried about the following points. (1) The authors present many hypotheses which are H1a, H1b, H2a, H2b, H3a, H3b, H4a, and H4b and analyze them quantitatively. The variable definitions and descriptive statistics are listed in Table1 and Table2 and the regression results for each model are shown the Table 3, Table 4, Table 5, Table 6, and Table 7. These results are then used to test the hypotheses and draw conclusions. However, the actual contents of Table1 and Table2 are black boxes, and there is no way to verify them. Also, there seems to be no explanation of the model from 1 to 4. (2) Also, regarding the INPI that means the total number of patents in Table 1, the results are not compared and discussed with those of Cappelen et al. (2012) and Moretti and Wilson (2014), which are cited as previous studies. There is no crucial discussion of how the current results in China differ from the results in those other countries and also the reason why in this manuscript. I cannot make an accurate judgment because I lack the materials to make a solid decision. Referee: 2 Comments to the Author Dear Author(s), Overall paper is very well written and meets the required standards. However, a few suggestions are put forward to make its worth reading. 1. Abstract: A paragraph on methodology can make it a comprehensive abstract. 2. Literature review should be updated with a few recent papers i.e. 2020-21 3. Methodology: Page 09, line 36, 'Special Treatment (ST*) need to be defined in comprehensive way for the readers. 4. Moderator: page 11, The author(s) should clearly explain the time line and technique used to collect the primary data. 5. VIF threshold reference is missing. Author(s) may consider to provide even conservative reference due to given results. 6. It was observed that Author(s) have used different styles of result reporting, it may be uniformed with providing beta value and p-values i.e. page 17, line 55-60 7. Discussion and Conclusion: Author(s) must add some references in (Point-2) to strengthen the discussion part as provided in the same section i.e. (1 and 3) 8. Page 30, line 47, I guess it must be competitiveness rather than 'competitive' 9. In my opinion, a separate section on limitations and future research directions can make study worth reading. Editor的主要傾向是：You will see that although the referees find some merit in the paper it is required that substantial revisions be done before we can consider it further. Nevertheless, we do hope that you will be able to undertake the additional work on the paper and look forward to receiving a revised manuscript in due course. 很惶恐！主編的意思是能不能中呢？還有Referee: 1在說的black boxes 是啥意思？是在說我的數(shù)據(jù)論證不清晰么？還是在覺得我數(shù)據(jù)不真實呢？？ 球球了 幫我給點意見吧�。。�！ 比心 |
回復(fù)此樓» 猜你喜歡
一志愿重慶大學085700資源與環(huán)境，總分308求調(diào)劑
已經(jīng)有6人回復(fù)
-
接收2026碩士調(diào)劑(學碩+專碩)
已經(jīng)有6人回復(fù)
-
081700 調(diào)劑 267分
已經(jīng)有5人回復(fù)
-
328求調(diào)劑
已經(jīng)有4人回復(fù)
-
0854 考研調(diào)劑 招生了！AI 方向
已經(jīng)有14人回復(fù)
-
招08考數(shù)學
已經(jīng)有14人回復(fù)
-
一志愿上海交大生物與醫(yī)藥專碩324分，求調(diào)劑
已經(jīng)有4人回復(fù)
-
0854電子信息求調(diào)劑 324
已經(jīng)有3人回復(fù)
-
303求調(diào)劑
已經(jīng)有3人回復(fù)
-
336求調(diào)劑
已經(jīng)有3人回復(fù)
9樓2022-06-14 22:05:53
1018415371
新蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 2134.5
- 散金: 2654
- 紅花: 2
- 帖子: 658
- 在線: 66.1小時
- 蟲號: 2881841
- 注冊: 2013-12-19
- 專業(yè): 自身免疫性疾病
2樓2022-06-10 08:36:25
SenX
金蟲 (正式寫手)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 1141.8
- 散金: 50
- 紅花: 1
- 帖子: 456
- 在線: 49.8小時
- 蟲號: 7696310
- 注冊: 2017-12-29
- 性別: GG
- 專業(yè): 遙感機理與方法
3樓2022-06-10 08:42:33
4樓2022-06-10 08:50:19
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 291 求調(diào)劑 +4 | 化工2026屆畢業(yè)?/a> 2026-03-21 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 276求調(diào)劑 +3 | YNRYG 2026-03-21 | 4/200 |
|
|
|
[考研] 352求調(diào)劑 +3 | 大米飯！ 2026-03-22 | 3/150 |
|
|
|
[考研] 308求調(diào)劑 +3 | 墨墨漠 2026-03-21 | 3/150 |
|
|
|
[考研] 289求調(diào)劑 +7 | 懷瑾握瑜l 2026-03-20 | 7/350 |
|
|
|
[考研] 求調(diào)劑院校信息 +6 | CX 330 2026-03-21 | 6/300 |
|
|
|
[考研] 資源與環(huán)境 調(diào)劑申請(333分) +5 | holy J 2026-03-21 | 5/250 |
|
|
|
[考研] 280求調(diào)劑 +11 | 咕嚕曉曉 2026-03-18 | 12/600 |
|
|
|
[考研] 278求調(diào)劑 +9 | 煙火先于春 2026-03-17 | 9/450 |
|
|
|
[考研] 一志愿重慶大學085700資源與環(huán)境總分308求調(diào)劑 +7 | 墨墨漠 2026-03-20 | 7/350 |
|
|
|
[考研] 299求調(diào)劑 +4 | 某某某某位 2026-03-21 | 4/200 |
|
|
|
[考研] 求調(diào)劑 +3 | 白QF 2026-03-21 | 3/150 |
|
|
|
[考研] 機械專碩299求調(diào)劑至材料 +3 | kkcoco25 2026-03-16 | 4/200 |
|
|
|
[考研] 化學求調(diào)劑 +4 | 臨澤境llllll 2026-03-17 | 5/250 |
|
|
|
[考研] 一志愿南京理工大學085701資源與環(huán)境302分求調(diào)劑 +4 | 葵梓衛(wèi)隊 2026-03-18 | 6/300 |
|
|
|
[考研] 一志愿 西北大學 ，070300化學學碩，總分287，雙非一本，求調(diào)劑。 +4 | 晨昏線與星海 2026-03-19 | 4/200 |
|
|
|
[考研] 295材料求調(diào)劑，一志愿武漢理工085601專碩 +5 | Charlieyq 2026-03-19 | 5/250 |
|
|
|
[考研] 0703化學調(diào)劑 +4 | 18889395102 2026-03-18 | 4/200 |
|
|
|
[考研] 085600材料與化工求調(diào)劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|
|
|
[考研] 【同濟軟件】軟件（085405）考研求調(diào)劑 +3 | 2026eternal 2026-03-18 | 3/150 |
|